TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

You Are Here: Home  »  Research  »  Epilepsy Research Web  » 

Skip secondary menu

Epilepsy Research Benchmarks Progress Update (2007-2009)

References cited:

    1. Saitsu, H., et al., De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet, 2008. 40(6): p. 782-8.
    2. Dibbens, L.M., et al., X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet, 2008. 40(6): p. 776-81.
    3. Bond, A.M., et al., Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nat Neurosci, 2009. 12(8): p. 1020-7.
    4. Colasante, G., et al., Arx is a direct target of Dlx2 and thereby contributes to the tangential migration of GABAergic interneurons. J Neurosci, 2008. 28(42): p. 10674-86.
    5. Friocourt, G., et al., Cell-autonomous roles of ARX in cell proliferation and neuronal migration during corticogenesis. J Neurosci, 2008. 28(22): p. 5794-805.
    6. Kato, M. and W.B. Dobyns, X-linked lissencephaly with abnormal genitalia as a tangential migration disorder causing intractable epilepsy: proposal for a new term, "interneuronopathy". J Child Neurol, 2005. 20(4): p. 392-7.
    7. Marsh, E., et al., Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females. Brain, 2009. 132(Pt 6): p. 1563-76.
    8. Okazaki, S., et al., Aristaless-related homeobox gene disruption leads to abnormal distribution of GABAergic interneurons in human neocortex: evidence based on a case of X-linked lissencephaly with abnormal genitalia (XLAG). Acta Neuropathol, 2008. 116(4): p. 453-62.
    9. Price, M.G., et al., A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J Neurosci, 2009. 29(27): p. 8752-63.
    10. Pearl, P.L., et al., Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency. Neurology, 2009. 73(6): p. 423-9.
    11. (CDC)., C.f.D.C.a.P., Neurologic complications associated with novel influenza A (H1N1) virus infection in children - Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep, 2009. 58(28): p. 773-8.
    12. Kawashima, H., et al., Cerebrospinal fluid analysis in children with seizures from respiratory syncytial virus infection. Scand J Infect Dis, 2009. 41(3): p. 228-31.
    13. McDermott, S., J.R. Mann, and J. Wu, Maternal genitourinary infection appears to synergistically increase the risk of epilepsy in children of women with epilepsy. Neuroepidemiology. 34(2): p. 117-22.
    14. Fotheringham, J., et al., Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med, 2007. 4(5): p. e180.
    15. Shinnar, S., et al., Phenomenology of prolonged febrile seizures: results of the FEBSTAT study. Neurology, 2008. 71(3): p. 170-6.
    16. Akman, C.I., et al., Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency. Dev Med Child Neurol, 2009. 51(7): p. 563-7.
    17. Buckmaster, P.S., E.A. Ingram, and X. Wen, Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy. J Neurosci, 2009. 29(25): p. 8259-69.
    18. Chen, S., et al., Alterations in mammalian target of rapamycin signaling pathways after traumatic brain injury. J Cereb Blood Flow Metab, 2007. 27(5): p. 939-49.
    19. Crino, P.B., Focal brain malformations: a spectrum of disorders along the mTOR cascade. Novartis Found Symp, 2007. 288: p. 260-72; discussion 272-81.
    20. Erlich, S., et al., Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis, 2007. 26(1): p. 86-93.
    21. Franz, D.N., mTOR in tuberous sclerosis and other neurological disorders. Epilepsia, 2007. 48(8): p. 1630-1; author reply 1632-4.
    22. Ljungberg, M.C., et al., Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Model Mech, 2009. 2(7-8): p. 389-98.
    23. Meikle, L., et al., Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci, 2008. 28(21): p. 5422-32.
    24. Wong, M., Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies. Epilepsia. 51(1): p. 27-36.
    25. Zeng, L.H., N.R. Rensing, and M. Wong, The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci, 2009. 29(21): p. 6964-72.
    26. Zeng, L.H., et al., Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol, 2008. 63(4): p. 444-53.
    27. Cacheaux, L.P., et al., Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J Neurosci, 2009. 29(28): p. 8927-35.
    28. Fabene, P.F., et al., A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med, 2008. 14(12): p. 1377-83.
    29. Friedman, A., D. Kaufer, and U. Heinemann, Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res, 2009. 85(2-3): p. 142-9.
    30. Ivens, S., et al., TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain, 2007. 130(Pt 2): p. 535-47.
    31. Marchi, N., et al., Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis, 2009. 33(2): p. 171-81.
    32. van Vliet, E.A., et al., Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain, 2007. 130(Pt 2): p. 521-34.
    33. Galic, M.A., et al., Postnatal inflammation increases seizure susceptibility in adult rats. J Neurosci, 2008. 28(27): p. 6904-13.
    34. Ravizza, T., et al., Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis, 2008. 29(1): p. 142-60.
    35. Ravizza, T., et al., Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol Dis, 2008. 31(3): p. 327-33.
    36. Riazi, K., et al., Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc Natl Acad Sci U S A, 2008. 105(44): p. 17151-6.
    37. Rodgers, K.M., et al., The cortical innate immune response increases local neuronal excitability leading to seizures. Brain, 2009. 132(Pt 9): p. 2478-86.
    38. Jabs, R., G. Seifert, and C. Steinhäuser, Astrocytic function and its alteration in the epileptic brain. Epilepsia, 2008. 49 Suppl 2: p. 3-12.
    39. Wetherington, J., G. Serrano, and R. Dingledine, Astrocytes in the epileptic brain. Neuron, 2008. 58(2): p. 168-78.
    40. Aronica, E., et al., Differential expression patterns of chloride transporters, Na+-K+-2Cl--cotransporter and K+-Cl--cotransporter, in epilepsy-associated malformations of cortical development. Neuroscience, 2007. 145(1): p. 185-96.
    41. Huberfeld, G., et al., Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy. J Neurosci, 2007. 27(37): p. 9866-73.
    42. Chudomel, O., et al., Age- and gender-related differences in GABAA receptor-mediated postsynaptic currents in GABAergic neurons of the substantia nigra reticulata in the rat. Neuroscience, 2009. 163(1): p. 155-67.
    43. Dzhala, V.I., A.C. Brumback, and K.J. Staley, Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol, 2008. 63(2): p. 222-35.
    44. Glykys, J., et al., Differences in cortical versus subcortical GABAergic signaling: a candidate mechanism of electroclinical uncoupling of neonatal seizures. Neuron, 2009. 63(5): p. 657-72.
    45. Kahle, K.T., et al., Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1. J Child Neurol, 2009. 24(5): p. 572-6.
    46. Mazarati, A., D. Shin, and R. Sankar, Bumetanide inhibits rapid kindling in neonatal rats. Epilepsia, 2009. 50(9): p. 2117-22.
    47. Muñoz, A., et al., Cation-chloride cotransporters and GABA-ergic innervation in the human epileptic hippocampus. Epilepsia, 2007. 48(4): p. 663-73.
    48. Nardou, R., Y. Ben-Ari, and I. Khalilov, Bumetanide, an NKCC1 antagonist, does not prevent formation of epileptogenic focus but blocks epileptic focus seizures in immature rat hippocampus. J Neurophysiol, 2009. 101(6): p. 2878-88.
    49. Rakhade, S.N. and F.E. Jensen, Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol, 2009. 5(7): p. 380-91.
    50. Silverstein, F.S. and F.E. Jensen, Neonatal seizures. Ann Neurol, 2007. 62(2): p. 112-20.
    51. Wittner, L., et al., The epileptic human hippocampal cornu ammonis 2 region generates spontaneous interictal-like activity in vitro. Brain, 2009. 132(Pt 11): p. 3032-46.
    52. Becker, A.J., et al., Transcriptional upregulation of Cav3.2 mediates epileptogenesis in the pilocarpine model of epilepsy. J Neurosci, 2008. 28(49): p. 13341-53.
    53. Heron, S.E., et al., Channelopathies in idiopathic epilepsy. Neurotherapeutics, 2007. 4(2): p. 295-304.
    54. Huang, Z., M.C. Walker, and M.M. Shah, Loss of dendritic HCN1 subunits enhances cortical excitability and epileptogenesis. J Neurosci, 2009. 29(35): p. 10979-88.
    55. Jung, S., et al., Progressive dendritic HCN channelopathy during epileptogenesis in the rat pilocarpine model of epilepsy. J Neurosci, 2007. 27(47): p. 13012-21.
    56. Richichi, C., et al., Mechanisms of seizure-induced 'transcriptional channelopathy' of hyperpolarization-activated cyclic nucleotide gated (HCN) channels. Neurobiol Dis, 2008. 29(2): p. 297-305.
    57. Wu, J., et al., GABA(A) receptor-mediated excitation in dissociated neurons from human hypothalamic hamartomas. Exp Neurol, 2008. 213(2): p. 397-404.
    58. Graef, J.D., et al., An acquired channelopathy involving thalamic T-type Ca2+ channels after status epilepticus. J Neurosci, 2009. 29(14): p. 4430-41.
    59. Kole, M.H., A.U. Bräuer, and G.J. Stuart, Inherited cortical HCN1 channel loss amplifies dendritic calcium electrogenesis and burst firing in a rat absence epilepsy model. J Physiol, 2007. 578(Pt 2): p. 507-25.
    60. Bragin, A., J. Engel, Jr., and R.J. Staba, High-frequency oscillations in epileptic brain. Curr Opin Neurol. 23(2): p. 151-6.
    61. Roch, C., et al., Predictive value of cortical injury for the development of temporal lobe epilepsy in 21-day-old rats: an MRI approach using the lithium-pilocarpine model. Epilepsia, 2002. 43(10): p. 1129-36.
    62. Lin, J.J., et al., Reduced neocortical thickness and complexity mapped in mesial temporal lobe epilepsy with hippocampal sclerosis. Cereb Cortex, 2007. 17(9): p. 2007-18.
    63. Kamida, T., et al., Edaravone, a free radical scavenger, retards the development of amygdala kindling in rats. Neurosci Lett, 2009. 461(3): p. 298-301.
    64. Echegoyen, J., et al., Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model. Epilepsy Res, 2009. 85(1): p. 123-7.
    65. Seeburg, D.P., et al., Critical role of CDK5 and Polo-like kinase 2 in homeostatic synaptic plasticity during elevated activity. Neuron, 2008. 58(4): p. 571-83.
    66. Seeburg, D.P. and M. Sheng, Activity-induced Polo-like kinase 2 is required for homeostatic plasticity of hippocampal neurons during epileptiform activity. J Neurosci, 2008. 28(26): p. 6583-91.
    67. Paradiso, B., et al., Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model. Proc Natl Acad Sci U S A, 2009. 106(17): p. 7191-6.
    68. Li, T., et al., Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest, 2008. 118(2): p. 571-82.
    69. Zhou, J., et al., Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci, 2009. 29(6): p. 1773-83.
    70. Blumenfeld, H., et al., Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia, 2008. 49(3): p. 400-9.
    71. Sarkisova, K.Y., et al., Spike-wave discharges are necessary for the expression of behavioral depression-like symptoms. Epilepsia. 51(1): p. 146-60.
    72. Cortez, M.A., et al., Infantile spasms and Down syndrome: a new animal model. Pediatr Res, 2009. 65(5): p. 499-503.
    73. Lee, C.L., et al., A new animal model of infantile spasms with unprovoked persistent seizures. Epilepsia, 2008. 49(2): p. 298-307.
    74. Scantlebury, M.H., et al., A model of symptomatic infantile spasms syndrome. Neurobiol Dis. 37(3): p. 604-12.
    75. Stewart, K.A., et al., Theiler's virus infection chronically alters seizure susceptibility. Epilepsia, 2009.
    76. Palop, J.J., et al., Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron, 2007. 55(5): p. 697-711.
    77. Palop, J.J. and L. Mucke, Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol, 2009. 66(4): p. 435-40.
    78. Muncy, J., I.J. Butler, and M.K. Koenig, Rapamycin reduces seizure frequency in tuberous sclerosis complex. J Child Neurol, 2009. 24(4): p. 477.
    79. Liao, W., et al., Altered functional connectivity and small-world in mesial temporal lobe epilepsy. PLoS One, 2010. 5(1): p. e8525.
    80. Morgan, R.J. and I. Soltesz, Nonrandom connectivity of the epileptic dentate gyrus predicts a major role for neuronal hubs in seizures. Proc Natl Acad Sci U S A, 2008. 105(16): p. 6179-84.
    81. van Dellen, E., et al., Long-term effects of temporal lobe epilepsy on local neural networks: a graph theoretical analysis of corticography recordings. PLoS One, 2009. 4(11): p. e8081.
    82. Rouach, N., et al., Astroglial metabolic networks sustain hippocampal synaptic transmission. Science, 2008. 322(5907): p. 1551-5.
    83. Ziemann, A.E., et al., Seizure termination by acidosis depends on ASIC1a. Nat Neurosci, 2008. 11(7): p. 816-22.
    84. Aujla, P.K., M.R. Fetell, and F.E. Jensen, Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model. Epilepsia, 2009. 50(4): p. 694-701.
    85. Vezzani, A., et al., ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. Curr Opin Investig Drugs. 11(1): p. 43-50.
    86. Vezzani, A., S. Balosso, and T. Ravizza, The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun, 2008. 22(6): p. 797-803.
    87. Brinkmann, B.H., et al., Multiscale electrophysiology format: an open-source electrophysiology format using data compression, encryption, and cyclic redundancy check. Conf Proc IEEE Eng Med Biol Soc, 2009. 2009: p. 7083-6.
    88. Engel, J., Jr., et al., High-frequency oscillations: what is normal and what is not? Epilepsia, 2009. 50(4): p. 598-604.
    89. Gardner, A.B., et al., Human and automated detection of high-frequency oscillations in clinical intracranial EEG recordings. Clin Neurophysiol, 2007. 118(5): p. 1134-43.
    90. Schevon, C.A., et al., Microphysiology of epileptiform activity in human neocortex. J Clin Neurophysiol, 2008. 25(6): p. 321-30.
    91. Schevon, C.A., et al., Spatial characterization of interictal high frequency oscillations in epileptic neocortex. Brain, 2009. 132(Pt 11): p. 3047-59.
    92. Urrestarazu, E., et al., Interictal high-frequency oscillations (100-500 Hz) in the intracerebral EEG of epileptic patients. Brain, 2007. 130(Pt 9): p. 2354-66.
    93. Worrell, G.A., et al., High-frequency oscillations in human temporal lobe: simultaneous microwire and clinical macroelectrode recordings. Brain, 2008. 131(Pt 4): p. 928-37.
    94. Man, C.B., et al., Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia, 2007. 48(5): p. 1015-8.
    95. Bell, M.L., et al., Epilepsy surgery outcomes in temporal lobe epilepsy with a normal MRI. Epilepsia, 2009. 50(9): p. 2053-60.
    96. Bruggemann, J.M., et al., Voxel-based morphometry in the detection of dysplasia and neoplasia in childhood epilepsy: limitations of grey matter analysis. J Clin Neurosci, 2009. 16(6): p. 780-5.
    97. Cash, S.S., et al., The human K-complex represents an isolated cortical down-state. Science, 2009. 324(5930): p. 1084-7.
    98. Chen, Q., et al., MRI-negative refractory partial epilepsy: role for diffusion tensor imaging in high field MRI. Epilepsy Res, 2008. 80(1): p. 83-9.
    99. Fauser, S., et al., Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients. Brain, 2006. 129(Pt 7): p. 1907-16.
    100. Jeha, L.E., et al., Surgical outcome and prognostic factors of frontal lobe epilepsy surgery. Brain, 2007. 130(Pt 2): p. 574-84.
    101. Kazemi, N.J., et al., Ictal SPECT statistical parametric mapping in temporal lobe epilepsy surgery. Neurology, 2010. 74(1): p. 70-6.
    102. Knowlton, R.C., et al., Magnetic source imaging versus intracranial electroencephalogram in epilepsy surgery: a prospective study. Ann Neurol, 2006. 59(5): p. 835-42.
    103. Knowlton, R.C., et al., Functional imaging: II. Prediction of epilepsy surgery outcome. Ann Neurol, 2008. 64(1): p. 35-41.
    104. Knowlton, R.C., et al., Functional imaging: I. Relative predictive value of intracranial electroencephalography. Ann Neurol, 2008. 64(1): p. 25-34.
    105. Knowlton, R.C., et al., Effect of epilepsy magnetic source imaging on intracranial electrode placement. Ann Neurol, 2009. 65(6): p. 716-23.
    106. Madan, N. and P.E. Grant, New directions in clinical imaging of cortical dysplasias. Epilepsia, 2009. 50 Suppl 9: p. 9-18.
    107. McDonald, C.R., et al., Regional neocortical thinning in mesial temporal lobe epilepsy. Epilepsia, 2008. 49(5): p. 794-803.
    108. Sutherling, W.W., et al., Influence of magnetic source imaging for planning intracranial EEG in epilepsy. Neurology, 2008. 71(13): p. 990-6.
    109. Theysohn, J.M., et al., The human hippocampus at 7 T--in vivo MRI. Hippocampus, 2009. 19(1): p. 1-7.
    110. Widjaja, E., et al., Subcortical alterations in tissue microstructure adjacent to focal cortical dysplasia: detection at diffusion-tensor MR imaging by using magnetoencephalographic dipole cluster localization. Radiology, 2009. 251(1): p. 206-15.
    111. Schachter, S.C., et al., Advances in the application of technology to epilepsy: the CIMIT/NIO Epilepsy Innovation Summit. Epilepsy Behav, 2009. 16(1): p. 3-46.
    112. Anderson, C.T., K. Davis, and G. Baltuch, An update on brain stimulation for epilepsy. Curr Neurol Neurosci Rep, 2009. 9(4): p. 327-32.
    113. Anderson, W.S., et al., Implantation of a responsive neurostimulator device in patients with refractory epilepsy. Neurosurg Focus, 2008. 25(3): p. E12.
    114.  Boon, P., et al., Electrical stimulation for the treatment of epilepsy. Neurotherapeutics, 2009. 6(2): p. 218-27.
    115. Lockman, J. and R.S. Fisher, Therapeutic brain stimulation for epilepsy. Neurol Clin, 2009. 27(4): p. 1031-40.
    116. Skarpaas, T.L. and M.J. Morrell, Intracranial stimulation therapy for epilepsy. Neurotherapeutics, 2009. 6(2): p. 238-43.
    117. Dudek, F.E., Commentary: a skeptical view of experimental gene therapy to block epileptogenesis. Neurotherapeutics, 2009. 6(2): p. 319-22.
    118. Gray, S.J., et al., Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB). Mol Ther, 2009. 18(3): p. 570-8.
    119. Löscher, W., M. Gernert, and U. Heinemann, Cell and gene therapies in epilepsy--promising avenues or blind alleys? Trends Neurosci, 2008. 31(2): p. 62-73.
    120. Noè, F., et al., Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain, 2008. 131(Pt 6): p. 1506-15.
    121. Riban, V., H.L. Fitzsimons, and M.J. During, Gene therapy in epilepsy. Epilepsia, 2009. 50(1): p. 24-32.
    122. Boison, D. and K.A. Stewart, Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation. Biochem Pharmacol, 2009. 78(12): p. 1428-37.
    123. Detlev, B., Cell and gene therapies for refractory epilepsy. Curr Neuropharmacol, 2007. 5(2): p. 115-25.
    124. Szybala, C., et al., Antiepileptic effects of silk-polymer based adenosine release in kindled rats. Exp Neurol, 2009. 219(1): p. 126-35.
    125. Faught, E., et al., Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures. Neurology, 2008. 71(20): p. 1586-93.
    126. Malawska, B. and K. Kulig, Brivaracetam: a new drug in development for epilepsy and neuropathic pain. Expert Opin Investig Drugs, 2008. 17(3): p. 361-9.
    127. Rogawski, M.A., Brivaracetam: a rational drug discovery success story. Br J Pharmacol, 2008. 154(8): p. 1555-7.
    128. Brodie, M.J., et al., Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial. Epilepsia, 2009. 50(8): p. 1899-909.
    129. Glauser, T., et al., Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology, 2008. 70(21): p. 1950-8.
    130. Ben-Menachem, E., et al., Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia, 2007. 48(7): p. 1308-17.
    131. Halász, P., et al., Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial. Epilepsia, 2009. 50(3): p. 443-53.
    132. Nohria, V. and E. Giller, Ganaxolone. Neurotherapeutics, 2007. 4(1): p. 102-5.
    133. Pieribone, V.A., et al., Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy. Epilepsia, 2007. 48(10): p. 1870-4.
    134. Elger, C., et al., Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia, 2009. 50(3): p. 454-63.
    135. Gil-Nagel, A., et al., Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurol Scand, 2009. 120(5): p. 281-7.
    136. Bialer, M., et al., Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res, 2009. 83(1): p. 1-43.
    137. 137.        Perucca, E., J. French, and M. Bialer, Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol, 2007. 6(9): p. 793-804.
    138. Freeman, J.M., et al., A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia, 2009. 50(2): p. 322-5.
    139. Muzykewicz, D.A., et al., Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy. Epilepsia, 2009. 50(5): p. 1118-26.
    140. Neal, E.G., et al., The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol, 2008. 7(6): p. 500-6.
    141. Lundgren, T., et al., Acceptance and Commitment Therapy and yoga for drug-refractory epilepsy: a randomized controlled trial. Epilepsy Behav, 2008. 13(1): p. 102-8.
    142. Robey, R.W., A. Lazarowski, and S.E. Bates, P-glycoprotein--a clinical target in drug-refractory epilepsy? Mol Pharmacol, 2008. 73(5): p. 1343-6.
    143. Bromfield, E., et al., A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav, 2008. 12(1): p. 187-90.
    144. Garriga-Canut, M., et al., 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat Neurosci, 2006. 9(11): p. 1382-7.
    145. Lian, X.Y., F.A. Khan, and J.L. Stringer, Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats. J Neurosci, 2007. 27(44): p. 12007-11.
    146. Stafstrom, C.E., et al., Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models. Ann Neurol, 2009. 65(4): p. 435-47.
    147. Stefanello, S., et al., Suicidal thoughts in epilepsy: a community-based study in Brazil. Epilepsy Behav. 17(4): p. 483-8.
    148. Tellez-Zenteno, J.F., et al., Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia, 2007. 48(12): p. 2336-44.
    149. Kobau, R., et al., Epilepsy surveillance among adults--19 States, Behavioral Risk Factor Surveillance System, 2005. MMWR Surveill Summ, 2008. 57(6): p. 1-20.
    150. Ettinger, A.B., et al., Are psychiatric disorders independent risk factors for new-onset epilepsy in older individuals? Epilepsy Behav. 17(1): p. 70-4.
    151. Berg, A.T., et al., Global cognitive function in children with epilepsy: a community-based study. Epilepsia, 2008. 49(4): p. 608-14.
    152. Fastenau, P.S., et al., Academic underachievement among children with epilepsy: proportion exceeding psychometric criteria for learning disability and associated risk factors. J Learn Disabil, 2008. 41(3): p. 195-207.
    153. Bhise, V.V., G.D. Burack, and D.E. Mandelbaum, Baseline cognition, behavior, and motor skills in children with new-onset, idiopathic epilepsy. Dev Med Child Neurol. 52(1): p. 22-6.
    154. Fastenau, P.S., et al., Neuropsychological status at seizure onset in children: risk factors for early cognitive deficits. Neurology, 2009. 73(7): p. 526-34.
    155. Hermann, B.P., et al., Growing up with epilepsy: a two-year investigation of cognitive development in children with new onset epilepsy. Epilepsia, 2008. 49(11): p. 1847-58.
    156. Sgobio, C., et al., Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. Biol Psychiatry. 67(6): p. 567-74.
    157. Karnam, H.B., et al., Effect of age on cognitive sequelae following early life seizures in rats. Epilepsy Res, 2009. 85(2-3): p. 221-30.
    158. Jones, N.C., et al., Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation. Exp Neurol, 2008. 209(1): p. 254-60.
    159. Ay, Y., et al., Neuropsychologic impairment in children with rolandic epilepsy. Pediatr Neurol, 2009. 41(5): p. 359-63.
    160. Völkl-Kernstock, S., et al., Speech and school performance in children with benign partial epilepsy with centro-temporal spikes (BCECTS). Seizure, 2009. 18(5): p. 320-6.
    161. Wilson, S.J., et al., Personality development in the context of intractable epilepsy. Arch Neurol, 2009. 66(1): p. 68-72.
    162. Taylor, J., et al., Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment? Epilepsia. 51(1): p. 48-56.
    163. Lin, H., et al., Recurrent seizures induce a reversible impairment in a spatial hidden goal task. Hippocampus, 2009. 19(9): p. 817-27.
    164. Caplan, R., et al., Frontal and temporal volumes in Childhood Absence Epilepsy. Epilepsia, 2009. 50(11): p. 2466-72.
    165. Lothe, A., et al., Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study. Brain, 2008. 131(Pt 10): p. 2765-82.
    166. McDonald, C.R., et al., Diffusion tensor imaging correlates of memory and language impairments in temporal lobe epilepsy. Neurology, 2008. 71(23): p. 1869-76.
    167. Pulsipher, D.T., et al., Thalamofrontal circuitry and executive dysfunction in recent-onset juvenile myoclonic epilepsy. Epilepsia, 2009. 50(5): p. 1210-9.
    168. Riley, J.D., et al., Altered white matter integrity in temporal lobe epilepsy: association with cognitive and clinical profiles. Epilepsia. 51(4): p. 536-45.
    169. Roebling, R., et al., Evaluation of cognition, structural, and functional MRI in juvenile myoclonic epilepsy. Epilepsia, 2009. 50(11): p. 2456-65.
    170. Voets, N.L., et al., Functional and structural changes in the memory network associated with left temporal lobe epilepsy. Hum Brain Mapp, 2009. 30(12): p. 4070-81.
    171. Zhang, Z., et al., Altered spontaneous neuronal activity of the default-mode network in mesial temporal lobe epilepsy. Brain Res.
    172. Everts, R., et al., Language lateralization correlates with verbal memory performance in children with focal epilepsy. Epilepsia. 51(4): p. 627-38.
    173. Buckner, R.L., J.R. Andrews-Hanna, and D.L. Schacter, The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci, 2008. 1124: p. 1-38.
    174. Dabbs, K., et al., Neuroanatomical correlates of cognitive phenotypes in temporal lobe epilepsy. Epilepsy Behav, 2009. 15(4): p. 445-51.
    175. Frings, L., et al., Remote effects of hippocampal damage on default network connectivity in the human brain. J Neurol, 2009. 256(12): p. 2021-9.
    176. Morgan, V.L., J.C. Gore, and B. Abou-Khalil, Cluster analysis detection of functional MRI activity in temporal lobe epilepsy. Epilepsy Res, 2007. 76(1): p. 22-33.
    177. Hermann, B.P., et al., Brain development in children with new onset epilepsy: A prospective controlled cohort investigation. Epilepsia.
    178. Badawy, R., et al., The peri-ictal state: cortical excitability changes within 24 h of a seizure. Brain, 2009. 132(Pt 4): p. 1013-21.
    179. Hasler, G., et al., 5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry, 2007. 62(11): p. 1258-64.
    180. Berg, A.T., et al., Residual cognitive effects of uncomplicated idiopathic and cryptogenic epilepsy. Epilepsy Behav, 2008. 13(4): p. 614-9.
    181. Dube, C.M., et al., Cognitive dysfunction after experimental febrile seizures. Exp Neurol, 2009. 215(1): p. 167-77.
    182. Karnam, H.B., et al., Early life seizures cause long-standing impairment of the hippocampal map. Exp Neurol, 2009. 217(2): p. 378-87.
    183. Chauvière, L., et al., Early deficits in spatial memory and theta rhythm in experimental temporal lobe epilepsy. J Neurosci, 2009. 29(17): p. 5402-10.
    184. Helmstaedter, C. and C.E. Elger, Chronic temporal lobe epilepsy: a neurodevelopmental or progressively dementing disease? Brain, 2009. 132(Pt 10): p. 2822-30.
    185. Jambaqué, I., et al., Verbal emotional memory in children and adolescents with temporal lobe epilepsy: a first study. Epilepsy Behav, 2009. 16(1): p. 69-75.
    186. Buizer-Voskamp, J.E., et al., Systematic genotype-phenotype analysis of autism susceptibility loci implicates additional symptoms to co-occur with autism. Eur J Hum Genet. 18(5): p. 588-95.
    187. Buchmayer, S., et al., Can association between preterm birth and autism be explained by maternal or neonatal morbidity? Pediatrics, 2009. 124(5): p. e817-25.
    188. Barry, J.J., et al., Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav, 2008. 13 Suppl 1: p. S1-29.
    189. Baptista-Neto, L., et al., An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy. Expert Opin Investig Drugs, 2008. 17(1): p. 77-84.
    190. Torres, A.R., J. Whitney, and J. Gonzalez-Heydrich, Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy Behav, 2008. 12(2): p. 217-33.
    191. Mazarati, A.M., et al., Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta. Neurobiol Dis. 37(2): p. 461-7.
    192. Ehninger, D., et al., Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med, 2008. 14(8): p. 843-8.
    193. Saling, M.M., Verbal memory in mesial temporal lobe epilepsy: beyond material specificity. Brain, 2009. 132(Pt 3): p. 570-82.
    194. Weintrob, D.L., et al., Impaired verbal associative learning after resection of left perirhinal cortex. Brain, 2007. 130(Pt 5): p. 1423-31.
    195. Lillywhite, L.M., et al., Differential contributions of the hippocampus and rhinal cortices to verbal memory in epilepsy. Epilepsy Behav, 2007. 10(4): p. 553-9.
    196. St-Laurent, M., et al., Determinants of autobiographical memory in patients with unilateral temporal lobe epilepsy or excisions. Neuropsychologia, 2009. 47(11): p. 2211-21.
    197. Staresina, B.P. and L. Davachi, Selective and shared contributions of the hippocampus and perirhinal cortex to episodic item and associative encoding. J Cogn Neurosci, 2008. 20(8): p. 1478-89.
    198. Haskins, A.L., et al., Perirhinal cortex supports encoding and familiarity-based recognition of novel associations. Neuron, 2008. 59(4): p. 554-60.
    199. Drane, D.L., et al., Category-specific recognition and naming deficits following resection of a right anterior temporal lobe tumor in a patient with atypical language lateralization. Cortex, 2009. 45(5): p. 630-40.
    200. Drane, D.L., et al., Category-specific naming and recognition deficits in temporal lobe epilepsy surgical patients. Neuropsychologia, 2008. 46(5): p. 1242-55.
    201. Yucus, C.J. and D. Tranel, Preserved proper naming following left anterior temporal lobectomy is associated with early age of seizure onset. Epilepsia, 2007. 48(12): p. 2241-52.
    202. Thomas, C., et al., Reduced structural connectivity in ventral visual cortex in congenital prosopagnosia. Nat Neurosci, 2009. 12(1): p. 29-31.
    203. Thomas, C., et al., Reduction in white matter connectivity, revealed by diffusion tensor imaging, may account for age-related changes in face perception. J Cogn Neurosci, 2008. 20(2): p. 268-84.
    204. Viskontas, I.V., R.Q. Quiroga, and I. Fried, Human medial temporal lobe neurons respond preferentially to personally relevant images. Proc Natl Acad Sci U S A, 2009. 106(50): p. 21329-34.
    205. Duffau, H., M. Thiebaut de Schotten, and E. Mandonnet, White matter functional connectivity as an additional landmark for dominant temporal lobectomy. J Neurol Neurosurg Psychiatry, 2008. 79(5): p. 492-5.
    206. Mandonnet, E., P. Gatignol, and H. Duffau, Evidence for an occipito-temporal tract underlying visual recognition in picture naming. Clin Neurol Neurosurg, 2009. 111(7): p. 601-5.
    207. Nashef, L. and S. Brown, Epilepsy and sudden death. Lancet, 1996. 348(9038): p. 1324-5.
    208. Bateman, L.M., C.S. Li, and M. Seyal, Ictal hypoxemia in localization-related epilepsy: analysis of incidence, severity and risk factors. Brain, 2008. 131(Pt 12): p. 3239-45.
    209. Seyal, M. and L.M. Bateman, Ictal apnea linked to contralateral spread of temporal lobe seizures: Intracranial EEG recordings in refractory temporal lobe epilepsy. Epilepsia, 2009. 50(12): p. 2557-62.
    210. Brotherstone, R., B. Blackhall, and A. McLellan, Lengthening of corrected QT during epileptic seizures. Epilepsia. 51(2): p. 221-32.
    211. Janszky, I., et al., Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy--the Stockholm Heart Epidemiology Program. Brain, 2009. 132(Pt 10): p. 2798-804.
    212. Neufeld, G., et al., Cardiac repolarization indices in epilepsy patients. Cardiology, 2009. 114(4): p. 255-60.
    213. Surges, R., et al., Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: a case-control study. Epilepsia. 51(2): p. 233-42.
    214. Surges, R., et al., Do alterations in inter-ictal heart rate variability predict sudden unexpected death in epilepsy? Epilepsy Res, 2009. 87(2-3): p. 277-80.
    215. Surges, R., C.A. Scott, and M.C. Walker, Enhanced QT shortening and persistent tachycardia after generalized seizures. Neurology. 74(5): p. 421-6.
    216. Goldman, A.M., et al., Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death. Sci Transl Med, 2009. 1(2): p. 2ra6.
    217. Sakamoto, K., et al., Autonomic consequences of kainic acid-induced limbic cortical seizures in rats: peripheral autonomic nerve activity, acute cardiovascular changes, and death. Epilepsia, 2008. 49(6): p. 982-96.
    218. Shen, H.Y., T. Li, and D. Boison, A novel mouse model for sudden unexpected death in epilepsy (SUDEP): role of impaired adenosine clearance. Epilepsia. 51(3): p. 465-8.
    219. Szabó, C.A., et al., Mortality in captive baboons with seizures: a new model for SUDEP? Epilepsia, 2009. 50(8): p. 1995-8.
    220. So, E.L., et al., Report of the American Epilepsy Society and the Epilepsy Foundation joint task force on sudden unexplained death in epilepsy. Epilepsia, 2009. 50(4): p. 917-22.
    221. Batista, B.H. and M.L. Nunes, Evaluation of sleep habits in children with epilepsy. Epilepsy Behav, 2007. 11(1): p. 60-4.
    222. Piperidou, C., et al., Influence of sleep disturbance on quality of life of patients with epilepsy. Seizure, 2008. 17(7): p. 588-94.
    223. Manni, R., M. Terzaghi, and E. Zambrelli, REM sleep behaviour disorder in elderly subjects with epilepsy: frequency and clinical aspects of the comorbidity. Epilepsy Res, 2007. 77(2-3): p. 128-33.
    224. Chihorek, A.M., B. Abou-Khalil, and B.A. Malow, Obstructive sleep apnea is associated with seizure occurrence in older adults with epilepsy. Neurology, 2007. 69(19): p. 1823-7.
    225. Malow, B.A., et al., Treating obstructive sleep apnea in adults with epilepsy: a randomized pilot trial. Neurology, 2008. 71(8): p. 572-7.
    226. Meador, K.J., et al., Pregnancy registries in epilepsy: a consensus statement on health outcomes. Neurology, 2008. 71(14): p. 1109-17.
    227. Pennell, P.B., et al., Pharmacology of antiepileptic drugs during pregnancy and lactation. Epilepsy Behav, 2007. 11(3): p. 263-9.
    228. Holmes, G.L., et al., Postnatal concerns in children born to women with epilepsy. Epilepsy Behav, 2007. 11(3): p. 270-6.
    229. Tomson, T., et al., Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries. Epilepsy Behav, 2007. 11(3): p. 277-82.
    230. Kaplan, P.W., et al., Obstetric risks for women with epilepsy during pregnancy. Epilepsy Behav, 2007. 11(3): p. 283-91.
    231. Meador, K.J., et al., Cognitive/behavioral teratogenetic effects of antiepileptic drugs. Epilepsy Behav, 2007. 11(3): p. 292-302.
    232. Harden, C.L., et al., Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology, 2009. 73(2): p. 126-32.
    233. Harden, C.L., et al., Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology, 2009. 73(2): p. 133-41.
    234. 234.        Harden, C.L., et al., Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology, 2009. 73(2): p. 142-9.
    235. Meador, K.J., et al., Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med, 2009. 360(16): p. 1597-605.
    236. Raffo, E., et al., Neurobehavioral maturation of offspring from epileptic dams: study in the rat lithium-pilocarpine model. Exp Neurol, 2009. 219(2): p. 414-23.
    237. Ensrud, K.E., et al., Antiepileptic drug use and rates of hip bone loss in older men: a prospective study. Neurology, 2008. 71(10): p. 723-30.
    238. Triantafyllou, N., et al., Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy. J Neurol Sci. 290(1-2): p. 131-4.
    239. Moro-Alvarez, M.J., et al., Bone disease induced by phenytoin therapy: clinical and experimental study. Eur Neurol, 2009. 62(4): p. 219-30.
    240. Verrotti, A., et al., A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy. Eur J Neurol, 2009.
    241. Benbadis, S.R., et al., Interrater reliability of EEG-video monitoring. Neurology, 2009. 73(11): p. 843-6.
    242. Plug, L., B. Sharrack, and M. Reuber, Conversation analysis can help to distinguish between epilepsy and non-epileptic seizure disorders: a case comparison. Seizure, 2009. 18(1): p. 43-50.
    243. Plug, L., B. Sharrack, and M. Reuber, Seizure metaphors differ in patients' accounts of epileptic and psychogenic nonepileptic seizures. Epilepsia, 2009. 50(5): p. 994-1000.
    244. Reuber, M., et al., Using interactional and linguistic analysis to distinguish between epileptic and psychogenic nonepileptic seizures: a prospective, blinded multirater study. Epilepsy Behav, 2009. 16(1): p. 139-44.
    245. Hoerth, M.T., et al., Clinical predictors of psychogenic nonepileptic seizures: a critically appraised topic. Neurologist, 2008. 14(4): p. 266-70.
    246. 246.        Syed, T.U., et al., A self-administered screening instrument for psychogenic nonepileptic seizures. Neurology, 2009. 72(19): p. 1646-52.
    247. Bodde, N.M., et al., Psychogenic non-epileptic seizures--definition, etiology, treatment and prognostic issues: a critical review. Seizure, 2009. 18(8): p. 543-53.
    248. Kaufman, K.R., et al., Psychogenic non-epileptic seizures, anticipatory grief and limited access to medical care. Acta Neurol Belg, 2009. 109(2): p. 136-41.
    249. Marchetti, R.L., et al., Psychiatric diagnoses of patients with psychogenic non-epileptic seizures. Seizure, 2008. 17(3): p. 247-53.
    250. Mazza, M., et al., Non-Epileptic Seizures (NES) are predicted by depressive and dissociative symptoms. Epilepsy Res, 2009. 84(2-3): p. 91-6.
    251. Quinn, M., M. Schofield, and W. Middleton, Conceptualization and treatment of psychogenic non-epileptic seizures. J Trauma Dissociation, 2008. 9(1): p. 63-84.
    252. Reuber, M., The etiology of psychogenic non-epileptic seizures: toward a biopsychosocial model. Neurol Clin, 2009. 27(4): p. 909-24.
    253. LaFrance, W.C., Jr., et al., Cognitive behavioral therapy for psychogenic nonepileptic seizures. Epilepsy Behav, 2009. 14(4): p. 591-6.
    254. Kuyk, J., et al., Psychological treatment of patients with psychogenic non-epileptic seizures: an outcome study. Seizure, 2008. 17(7): p. 595-603.
    255. Howlett, S. and M. Reuber, An augmented model of brief psychodynamic interpersonal therapy for patients with nonepileptic seizures. . Psychotherapy: Theory, Research, Practice, Training. , 2009. 46(1): p. 125-138.
    256. Barry, J.J., et al., Group therapy for patients with psychogenic nonepileptic seizures: a pilot study. Epilepsy Behav, 2008. 13(4): p. 624-9.
    257. LaFrance, W.C., Jr., et al., Methodological issues in conducting treatment trials for psychological nonepileptic seizures. J Neuropsychiatry Clin Neurosci, 2007. 19(4): p. 391-8.
    258. LaFrance, W.C., Jr., M.D. Rusch, and J.T. Machan, What is "treatment as usual" for nonepileptic seizures? Epilepsy Behav, 2008. 12(3): p. 388-94.

Last Modified August 26, 2010